Clinical Trials in Nashville

Showing 6101-6120 of 20,298 trials

Brain Tissue Specimen Collection

NCT00593203

The Molecular Neurosurgical Tissue Bank will function as a tissue or specimen repository for biopsy specimens from patients (both adult and pediatric) undergoing brain surgery and brain procedures.

Brain Diseases

Vanderbilt University Medical Center2,500 participantsStarted May 2003

Nashville, Tennessee, United States

COMPLETEDPhase 2< 1 mile

Open-Label Study of Setmelanotide in Hypothalamic Obesity

NCT04725240

Open-label, single-arm study designed to evaluate the body weight response to setmelanotide administered subcutaneously (SC) daily in participants with hypothalamic obesity (HO).

Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc.18 participantsStarted Jun 2021

San Diego, California, United States • Gainesville, Florida, United States • Saint Paul, Minnesota, United States +2 more locations

TERMINATEDPhase 2< 1 mile

Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy

NCT04456517

Crohn's disease is an inflammatory disorder that can affect any part of the gastrointestinal (GI) tract. Some patients still experience persistent diarrhea or other symptoms such as abdominal pain even when their Crohn's disease is in remission. Diarrhea and/or abdominal pain that is not responsive to standard therapies can significantly affect a patient's quality of life and ability to work. The purpose of this study is to test the safety and effectiveness of the drug ranolazine in reducing Crohn's disease-associated diarrhea and other symptoms. Ranolazine is approved by the US Food \& Drug Administration (FDA) for chronic angina (a heart condition). This study is investigating if ranolazine could be used in the setting of Crohn's disease.

Crohn's DiseaseInflammatory Bowel Disease

Vanderbilt University Medical Center4 participantsStarted Oct 2022

Nashville, Tennessee, United States

Brain Tissue Specimen Collection

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy

Find Trials by Condition in Nashville

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Comparative Effectiveness of Operative Versus Non-Operative Treatments for Rotator Cuff Tears

Framing Eighteen Coils in Cerebral Aneurysms Trial

Nutrition, Inflammation and Insulin Resistance in End Stage Renal Disease-Aim 2

Predictive Analytics and Behavioral Nudges to Improve Palliative Care in Advanced Cancer

Different Doses of Naronapride Vs. Placebo in Gastroparesis

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD

A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)

A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease

Rituximab + Immunotherapy in Follicular Lymphoma

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy